Back to search results

Temporary Vessel Clamping for Myomectomy Blood Loss

This study is looking at whether temporarily clamping the blood vessels to the uterus and ovaries during a minimally invasive myomectomy (surgery to remove fibroids) can reduce blood loss. Doctors will temporarily clamp these vessels in some patients during their surgery. The study aims to see if this technique helps reduce the amount of blood lost during the procedure. You might be able to join if you are a woman aged 18 or older, having a minimally invasive myomectomy for a single fibroid 5cm or larger, or for five or more fibroids. You cannot participate if you are pregnant, under 18, having other surgeries at the same time, or have suspected cancer. The study is currently unclear on its recruitment status, but plans to enroll 120 participants.

Study design
This is an interventional study planning to enroll 120 women. It compares temporary clamping of uterine and ovarian vessels during surgery to no clamping.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, estimated blood loss, is measured during surgery, which is less than 24 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07182045

Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.

Recruiting
NAAges 18+InterventionalTreatment
The University of Texas Health Science Center, Houston
~120 participants
Updated 2026-05-14 on ClinicalTrials.gov
What's tested:Temporary clamping of uterine and ovarian vessels

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Estimated blood loss
Measured over Intraoperative (during surgery, which is < 24 hours)

Conditions

Myoma
Surgery

Explore related trials

Uterine Corpus Leiomyoma

NCT07182045

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Memorial Hermann Hospital

    Houston, Texasstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Randa Jalloul, MD
[email protected]
3137128603
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patient undergoing minimally invasive myomectomy with either a single intramural or Submucosal fibroid =/\>5cm or
Patients undergoing minimally invasive Myomectomy with =/\> 5 fibroids

Exclusion

Pregnancy,
Age \<18yo,
Patients undergoing concomitant surgery such as endometriosis surgery,
Suspected malignancy

What this trial measures

  • Estimated blood lossIntraoperative (during surgery, which is < 24 hours)

    Estimated blood loss during the surgery between groups, calculated by suction prior to irrigation.